Advanced, Cross-Disciplinary

1
Advanced, Cross-Disciplinary IntegratedMedical
Imagingfor all EUropeans through aNetwork of
Regional Clusters andDevelOPment
StratEgiesAMI-4EUROPE

• FP7-2010-REGIONS-1
• Topic Call Addressed
• Support economic development by boosting the
• competitiveness of health-related economy

Assistant Professor Bogdan Ionel Tamba, M.D.,
PhD. Translational Pain Research Group Gr.T.Popa
Biomedical Research Centre
2
(No Transcript)
3
(No Transcript)
4
Impasul actual
Cheltuieli RD vs. aprobari FDA, 1996-2006
si totusi mai putine autorizari
Cheltuielile RD cresc anual
Autorizari de noi medicamente
Cheltuieli RD
Surse PhRMA 2007 FDA 2007
5
Antibioticele
6
(No Transcript)
7
Value chain analysis
8
(No Transcript)
9
Actorii principali

• Cercetare fundamentala (academia, institute de
  cercetare, SME)
• Cercetare clinica (academia, organizatii de
  cercetare prin contract, spitale)
• Educatie (academia, ONG, guvern)
• Business (OCC, IMM-uri, companii farmaceutice
  mari)

10
How?

• co-ordination and integration of Research-Driven
  Clusters
• Triple Helix III approach
• university,
• industry,
• government,
• a must in order to achieve the growth and
  competitiveness opportunities that Advanced
  Medical Imaging brings to the European society.

11
Aims of AMI-4EUROPE

• to acquire a comprehensive insight into the
  design, implementation and impact of existing
  Medical Imaging and associated Health-related
  Technologies research and innovation support
  programs and initiatives in Europe.
• to create the Common Co-ordination and Knowledge
  Base necessary to enter the identified market
  niches
• to establish appropriate scientific advice and
  sustainable support mechanisms to assist the EC
  and national, regional policy makers
• to maximize the socio-economic impact in support
  of the health-related economy.

12
Finances

• The total requested grant is 2.682.504 from a
  total budget of 3.225.844

13
Impact

• to mobilize European health-related economy
  stakeholders
• to create an environment in which enterprises can
  start, grow and thrive,
• support the competitiveness and sustainable
  development in the Advanced Medical Imaging
  market that Europe requires.

14
Partner list
15
Why?

• Thanks to the developments in Medical Imaging,
  Diagnosis is earlier than ever.
• Physicians have more information and insight.
  Care is less invasive and less painful for
  patients.
• Access to tests and treatments is easier as
  imaging procedures are available in convenient
  settings, such as independent imaging centers.
• In addition, patient outcomes from fewer
  complications to saved livesare dramatically
  improved.
• Unfortunately, the healthcare sector is diverse
  and as a result, collaboration has been difficult
  
• The challenge is to build expertise in the
  development of integrated systems that address
  unmet clinical needs while providing a solid and
  consistent network of RD Innovation groups.

16
Todays directions
17
Source (Hoffman, 2006) Countries colored in
brown rank highly in the Growth Competitiveness
Index 20042005.
18

• Alsace BioValley www.alsace-biovalley.com Alsace
  region (France)
• Atlantpole www.atlanpole.fr Nantes Atlantic
  region (France)
• Barcelona Science Park www.pcb.ub.es Barcelona
• The BioIndustry Association www.bioindustry.org UK
  
• BioApproaches SW www.bioapproaches.co.uk South-Wes
  t of England
• BioBASK Agency (SPRI) www.biobask.org Basque
  region
• BioCity Nottingham www.biocity.co.uk Nottingham
  (UK)
• BioDundee www.biodundee.co.uk Dundee (Scotland)
• Bioindustry Park del Canavese SpA www.bioindustryp
  ark.eu Piemonte region (Italy)
• BioInstruments Jena www.bioinstrumente-jena.de Jen
  a (Germany)
• bioKnex www.bioknex.org East Midlands of England
• BioLiège www.bioliege.org Liège (Belgium)
• BioM www.bio-m.de Munich region (Germany)
• BioMadrid www.biomadrid.org Madrid region
• Bionow, NWDA www.bionow.co.uk North West of
  England
• BioPartner www.biopartner.co.uk U.K.
• BioRegion of Catalonia www.biocat.cat Catalonia
  region
• Biosaxony www.biosaxony.com State of Saxony in
  Germany
• Biotechnologies France biotech.education.fr France
  

19

• ERBI Ltd www.erbi.co.uk East of England
• Estonian Biotechnology Association www.biotech.ee/
  Estonia
• EuropaBio www.europabio.org Europe
• European Federation of Biotechnology www.efb-centr
  al.org Europe
• FlandersBio www.flandersbio.be Flanders
  (Belgium)
• France Biotech www.france-biotech.org France
• Genopole www.genopole.fr Paris region
• Hungarian Biotechnology Association www.hungarianb
  iotech.org Hungary
• Kent Bioscience Network www.kentbio.co.uk Sittingb
  ourne (England) N
• Life Science Austria Vienna Region www.lisavr.at V
  ienna Region
• London Biotechnology Network www.londonbiotechnolo
  gy.co.uk London region N
• Medicon Valley Academy www.mva.org Copenhagen
  region (Denmark) and the Skäne region (Southern
  Sweden)
• MidiBiotech www.midibiotech.org Midi-Pyrénées
  region (France)
• Nexxus www.nexxusscotland.com West of Scotland N
• Norgenta www.norgenta.de North of Germany
• Ostjysk Innovation www.oei.dk Aarhus (Denmark)
• Oxfordshire Bioscience Network www.oxfordshirebios
  cience.net Oxfordshire region
• Pharmalicensing pharmalicensing.com UK
• South East Health Technologies Alliance
  (SEHTA) www.sehta.co.uk South East of England

20
(No Transcript)
21
(No Transcript)
22
Va multumesc

• Dr. Bogdan Ionel Tamba
• bitamba_at_mail.umfiasi.ro